On Monday, Ensysce Biosciences Inc (NASDAQ: ENSC) was 19.46% up from the session before settling in for the closing price of $0.49. A 52-week range for ENSC has been $0.14 – $2.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -10.06%. When this article was written, the company’s average yearly earnings per share was at 82.30%. With a float of $19.18 million, this company’s outstanding shares have now reached $19.57 million.
Considering the fact that the conglomerate employs 9 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -337.58%, operating margin of -629.33%, and the pretax margin is -790.68%.
Ensysce Biosciences Inc (ENSC) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ensysce Biosciences Inc stocks. The insider ownership of Ensysce Biosciences Inc is 2.00%, while institutional ownership is 26.55%.
Ensysce Biosciences Inc (ENSC) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.37 earnings per share (EPS) during the time that was less than consensus figure (set at -0.81) by -0.56. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.30% per share during the next fiscal year.
Ensysce Biosciences Inc (NASDAQ: ENSC) Trading Performance Indicators
You can see what Ensysce Biosciences Inc (ENSC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.82, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Ensysce Biosciences Inc (ENSC)
Compared to the last year’s volume of 8.26 million, its volume of 1.66 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 33.44%. Additionally, its Average True Range was 0.10.
During the past 100 days, Ensysce Biosciences Inc’s (ENSC) raw stochastic average was set at 53.63%, which indicates a significant increase from 43.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 189.53% in the past 14 days, which was lower than the 232.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4192, while its 200-day Moving Average is $0.5375. Nevertheless, the first resistance level for the watch stands at $0.6451 in the near term. At $0.7001, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7803. If the price goes on to break the first support level at $0.5099, it is likely to go to the next support level at $0.4297. Now, if the price goes above the second support level, the third support stands at $0.3747.
Ensysce Biosciences Inc (NASDAQ: ENSC) Key Stats
There are 19,574K outstanding shares of the company, which has a market capitalization of 11.38 million. As of now, sales total 2,230 K while income totals -10,610 K. Its latest quarter income was 3,420 K while its last quarter net income were 660 K.
